Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 121267916 | 12126791 | 6 | F | 20150225 | 20160712 | 20160229 | 20160714 | EXP | DE-AMGEN-DEUNI2015041412 | AMGEN | 49.00 | YR | A | M | Y | 0.00000 | 20160714 | MD | DE | DE |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 121267916 | 12126791 | 1 | PS | panitumumab | PANITUMUMAB | 1 | Intravenous (not otherwise specified) | 690 MG, Q2WK | 71.2259979 | MG | 1053638 | 125147 | 690 | MG | SOLUTION FOR INJECTION | QOW | |||
| 121267916 | 12126791 | 2 | SS | panitumumab | PANITUMUMAB | 1 | Intravenous (not otherwise specified) | 700 UNK, UNK | 71.2259979 | MG | 1061415 | 125147 | SOLUTION FOR INJECTION | ||||||
| 121267916 | 12126791 | 3 | SS | panitumumab | PANITUMUMAB | 1 | Intravenous (not otherwise specified) | UNK | 71.2259979 | MG | 1056415 | 125147 | SOLUTION FOR INJECTION | ||||||
| 121267916 | 12126791 | 4 | SS | panitumumab | PANITUMUMAB | 1 | Intravenous (not otherwise specified) | 590 UNK, UNK | 71.2259979 | MG | 1060153 | 125147 | SOLUTION FOR INJECTION | QOW | |||||
| 121267916 | 12126791 | 5 | SS | panitumumab | PANITUMUMAB | 1 | Intravenous (not otherwise specified) | 590 UNK, UNK | 71.2259979 | MG | 1061630 | 125147 | SOLUTION FOR INJECTION | QOW | |||||
| 121267916 | 12126791 | 6 | C | CALCIUM FOLINATE W/FLUOROURACIL | 2 | Intravenous (not otherwise specified) | 75 UNK, UNK | 0 | |||||||||||
| 121267916 | 12126791 | 7 | C | 5-FU | FLUOROURACIL | 1 | Intravenous (not otherwise specified) | 6084 MG, UNK | 0 | 6084 | MG | ||||||||
| 121267916 | 12126791 | 8 | C | IRINOTECAN | IRINOTECAN | 1 | Intravenous (not otherwise specified) | 188 UNK, QWK | 0 | /wk | |||||||||
| 121267916 | 12126791 | 9 | C | MEDOXA | 2 | Intravenous (not otherwise specified) | 234 MG/M2, Q2WK | 680.72699 | MG/M2 | 0 | 234 | MG/M**2 | QOW | ||||||
| 121267916 | 12126791 | 10 | C | RIBOFOLIN | 2 | Intravenous (not otherwise specified) | 400 MG/M2, Q2WK | 1163.63599 | MG/M2 | 0 | 400 | MG/M**2 | QOW | ||||||
| 121267916 | 12126791 | 11 | C | RIBOFLUOR | FLUOROURACIL | 1 | Intravenous (not otherwise specified) | 2400 MG/M2, Q2WK | 6981.81787 | MG/M2 | 0 | 2400 | MG/M**2 | QOW |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 121267916 | 12126791 | 1 | Colon cancer metastatic |
| 121267916 | 12126791 | 6 | Colon cancer metastatic |
| 121267916 | 12126791 | 7 | Colon cancer metastatic |
| 121267916 | 12126791 | 9 | Colon cancer metastatic |
| 121267916 | 12126791 | 10 | Colon cancer metastatic |
| 121267916 | 12126791 | 11 | Colon cancer metastatic |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 121267916 | 12126791 | HO |
| 121267916 | 12126791 | DE |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 121267916 | 12126791 | Colon cancer | |
| 121267916 | 12126791 | Rash |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 121267916 | 12126791 | 1 | 20150218 | 0 | ||
| 121267916 | 12126791 | 6 | 20150513 | 0 | ||
| 121267916 | 12126791 | 7 | 20150121 | 20160208 | 0 | |
| 121267916 | 12126791 | 8 | 20151028 | 0 | ||
| 121267916 | 12126791 | 9 | 20150121 | 20160208 | 0 | |
| 121267916 | 12126791 | 10 | 20150121 | 20160208 | 0 | |
| 121267916 | 12126791 | 11 | 20150121 | 20160208 | 0 |